Direkt zum Inhalt

Fazzini, F. ; Lamina, C. ; Raftopoulou, A. ; Koller, A. ; Fuchsberger, C. ; Pattaro, C. ; Del Greco, F. M. ; Döttelmayer, P. ; Fendt, L. ; Fritz, J. ; Meiselbach, H. ; Schönherr, S. ; Forer, L. ; Weissensteiner, H. ; Pramstaller, P. P. ; Eckardt, K.‐U. ; Hicks, A. A. ; Kronenberg, Florian ; Oefner, Peter ; Gronwald, Wolfram

Association of mitochondrial DNA copy number with metabolic syndrome and type 2 diabetes in 14 176 individuals

Article

Fazzini, F., Lamina, C., Raftopoulou, A., Koller, A., Fuchsberger, C., Pattaro, C., Del Greco, F. M., Döttelmayer, P., Fendt, L., Fritz, J., Meiselbach, H., Schönherr, S., Forer, L., Weissensteiner, H., Pramstaller, P. P., Eckardt, K.‐U., Hicks, A. A., Kronenberg, Florian , Oefner, Peter and Gronwald, Wolfram (2021) Association of mitochondrial DNA copy number with metabolic syndrome and type 2 diabetes in 14 176 individuals. Journal of Internal Medicine, (Early View).

DOI to cite this document: 10.5283/epub.45894


Abstract

Background Mitochondria play an important role in cellular metabolism, and their dysfunction is postulated to be involved in metabolic disturbances. Mitochondrial DNA is present in multiple copies per cell. The quantification of mitochondrial DNA copy number (mtDNA-CN) might be used to assess mitochondrial dysfunction. Objectives We aimed to investigate the cross-sectional association of ...

Background
Mitochondria play an important role in cellular metabolism, and their dysfunction is postulated to be involved in metabolic disturbances. Mitochondrial DNA is present in multiple copies per cell. The quantification of mitochondrial DNA copy number (mtDNA-CN) might be used to assess mitochondrial dysfunction.
Objectives
We aimed to investigate the cross-sectional association of mtDNA-CN with type 2 diabetes and the potential mediating role of metabolic syndrome.
Methods
We examined 4812 patients from the German Chronic Kidney Disease (GCKD) study and 9364 individuals from the Cooperative Health Research in South Tyrol (CHRIS) study. MtDNA-CN was measured in whole blood using a plasmid-normalized qPCR-based assay.
Results
In both studies, mtDNA-CN showed a significant correlation with most metabolic syndrome parameters: mtDNA-CN decreased with increasing number of metabolic syndrome components. Furthermore, individuals with low mtDNA-CN had significantly higher odds of metabolic syndrome (OR = 1.025; 95% CI = 1.011–1.039, P = 3.19 × 10−4, for each decrease of 10 mtDNA copies) and type 2 diabetes (OR = 1.027; 95% CI = 1.012–1.041; P = 2.84 × 10−4) in a model adjusted for age, sex, smoking and kidney function in the meta-analysis of both studies. Mediation analysis revealed that the association of mtDNA-CN with type 2 diabetes was mainly mediated by waist circumference in the GCKD study (66%) and by several metabolic syndrome parameters, especially body mass index and triglycerides, in the CHRIS study (41%).
Conclusions
Our data show an inverse association of mtDNA-CN with higher risk of metabolic syndrome and type 2 diabetes. A major part of the total effect of mtDNA-CN on type 2 diabetes is mediated by obesity parameters.



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleJournal of Internal Medicine
PublisherWiley
Page Range(Early View)
Date16 January 2021
Date of publication31 May 2021 09:55
InstitutionsMedicine > Institut für Funktionelle Genomik > Lehrstuhl für Funktionelle Genomik (Prof. Oefner)
Identification Number
ValueType
10.1111/joim.13242DOI
Keywordschronic kidney disease, diabetes, metabolic syndrome, mitochondrial DNA copy number
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgPartially
URN of the UB Regensburgurn:nbn:de:bvb:355-epub-458944
Item ID45894

Export bibliographical data

Owner only: item control page

nach oben